Antibody Drug Conjugate

Overview

Antibody Drug Conjugates (ADC) work by combining a chemotherapy drug with a monoclonal antibody. This allows the chemotherapy drug to target a specific cancer cell while limiting the damage to healthy cells.

Explore Tags

Myeloma Treatments

The following is a listing of myeloma treatments associated with this tag.

All Treatments

View all treatments in development for myeloma patients around the US.

Verified GSK2857916
GSK2857916

GSK2857916 is an antibody-drug conjugate (ADC) directed against the B-cell maturation antigen (BCMA).

Verified SGN-CD48A
SGN-CD48A

SGN-CD48A is an antibody-drug conjugate (ADC) directed against the CD48 protein.

SparkCures Verified Accurate, up-to-date information. Learn more


Early Relapse Multiple Myeloma

The following is a listing of treatments in development for patients with multiple myeloma who have received one to two prior lines of therapy.

Verified GSK2857916
GSK2857916

GSK2857916 is an antibody-drug conjugate (ADC) directed against the B-cell maturation antigen (BCMA).

Verified SGN-CD48A
SGN-CD48A

SGN-CD48A is an antibody-drug conjugate (ADC) directed against the CD48 protein.

SparkCures Verified Accurate, up-to-date information. Learn more


Late Relapse Multiple Myeloma

The following is a listing of treatments in development for patients with multiple myeloma who have received three or more prior lines of therapy.

Verified GSK2857916
GSK2857916

GSK2857916 is an antibody-drug conjugate (ADC) directed against the B-cell maturation antigen (BCMA).

Verified SGN-CD48A
SGN-CD48A

SGN-CD48A is an antibody-drug conjugate (ADC) directed against the CD48 protein.

SparkCures Verified Accurate, up-to-date information. Learn more


Myeloma Clinical Trials

The following is a listing of myeloma clinical trials associated with this tag.

Early Relapse Multiple Myeloma

The following is a listing of clinical trials for patients with multiple myeloma who have received one to two prior lines of therapy.

Late Relapse Multiple Myeloma

The following is a listing of clinical trials for patients with multiple myeloma who have received three or more prior lines of therapy.

Smoldering Myeloma
Monoclonal Gammopathy of Undetermined Significance (MGUS)
Myeloma Tags

The following is a listing of myeloma tags that are associated with this tag.

B-Cell Maturation Antigen (BCMA)

B-Cell Maturation Antigen (BCMA) is a protein that may be found on the surface of myeloma cells. BCMA may be used as a target to help treatments find and destroy myeloma cells.

CD48

CD48 is a protein that is found on the surface of myeloma cells. This protein may be used as a way for treatments to target and find the myeloma cells.

Resources